Effects of methylation of deiodinase 3 gene on gene expression and severity of Kashin–Beck disease

Z Li, D Zhang, Q Li, X Yang, R Zhang… - Journal of cellular …, 2020 - Wiley Online Library
Z Li, D Zhang, Q Li, X Yang, R Zhang, D Zhang, X Yang, C Wang, X Tan, Y Xiong
Journal of cellular physiology, 2020Wiley Online Library
Kashin–Beck disease (KBD) is a complex endemic osteoarthropathy, which mainly occurs in
the northeast to southwest China. Iodothyronine deiodinases 3 (DIO3) is one of the
selenoproteins, which is closely related to bone metabolism and unclear to KBD. This study
aims to investigate the role and associated mechanisms of methylation and expression of
DIO3 with disease severity in patients with KBD. We performed a bioinformatics analysis first
to identify the biological mechanisms involved in selenoproteins. The methylation status of …
Abstract
Kashin–Beck disease (KBD) is a complex endemic osteoarthropathy, which mainly occurs in the northeast to southwest China. Iodothyronine deiodinases 3 (DIO3) is one of the selenoproteins, which is closely related to bone metabolism and unclear to KBD. This study aims to investigate the role and associated mechanisms of methylation and expression of DIO3 with disease severity in patients with KBD. We performed a bioinformatics analysis first to identify the biological mechanisms involved in selenoproteins. The methylation status of the DIO3 gene and DIO3 gene expression, as well as DIO3‐related regulatory genes in patients with KBD, were analyzed. We found that 15 CpG sites of six selenoproteins were hypomethylated with 5‐azacytidine treatment. DIO3 hypermethylation was associated with an increased risk of KBD and may lead to downregulation of DIO3 gene expression as well as be an indicator of the severity of KBD, which may provide a new insight for gene–environment correlations and interactions in etiology and pathogenesis of KBD.
Wiley Online Library